HCP portal | Banner - 7

10 Thing You Should Know about 2025 ESC Dyslipidemia Guideline Update

Discover a concise overview of the 2025 ESC focused update on dyslipidemia management, with emphasis on what matters for day‑to‑day care.

The update outlines revised risk stratification, treatment targets, and sequencing of lipid‑lowering therapies, along with guidance on when to intensify beyond statins and how to individualize therapy in special populations!

 

READ MORE

Key Highlights:

  • A groundbreaking LDL extreme risk goal
  • CAC Score: Revamped recommendations
  • Are statins still the first choice?
  • The urgency of LDL lowering in Acs
  • Lipoprotein(a) Screening: Is it now essential?
  • Statin in PLWH & Cancer: Really needed?
  • Dietary supplements: ESC stamp of approval?
  • TG/HDL ratio and sdLDL: any recommendation yet?
  • LDL reduction and atherosclerotic plaque?
  • Statin side effects-what’s true and what’s not?